CVS Health (CVS)
$65.00
0.10 (0.15%)
CVS Stock Quote Delayed 30 Minutes
Flu Season Is Coming — And These Companies Are Ready
Flu season is slowly getting started -- bad news for us, but welcome news for companies that benefit from flu sufferers' ills. Here's a look at some of them.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$65.72
Market Cap
82.86B
PE Ratio
17.78
EPS
3.656
Volume (Avg. Vol.)
6.92M
Day's Range
$64.32 - $66.36
52-Week Range
$42.93 - $77.01
Dividend & Yield
$2.66 (4.09%)
CVS Stock Predictions, Articles, and CVS Health News
Go Ahead, Be Dumb. Buy Rite Aid
It's really quite simple: Drugstores are dead. Don't buy them. Ever.
Pharmacy Wars: Walgreens vs. CVS
The two largest U.S. pharmacy chains have both come roaring back, but which one -- CVS or Walgreens -- is the better bet for investors? Let's break it down.
Pfizer Spares Patients From Erectile Dysfunction Embarrassment
Pfizer has created an industry first by selling its successful Viagra pill directly to consumers -- a move that has implications for major drugmakers and pharmacies alike.
S&P 500 Returns to the Record Books — Monday’s IP Market Recap
Tech stocks helped lead a broader market rally Monday that pushed the S&P 500 to a new high of 1593.61.
For Health Insurers Investors, Uncertainty Equals Opportunity
Investors are getting mixed signals from health insurers over the Affordable Care Act. Use uncertainty to your advantage by buying their stocks on pullbacks.
Should I Buy Rite Aid? 3 Pros, 3 Cons
Rite Aid's turnaround continues to gain traction, but does that make it a solid investment? Decide by looking at RAD's pros and cons.
Healthcare Stocks Heat Up — Tuesday’s IP Market Recap
A change in reimbursement rates for Medicare Advantage helped propel healthcare stocks Tuesday. That, coupled with positive economic data, pushed the major indices higher.
The Cold Hard, Truth Behind Walmart Sales
Walmart's apparent sales struggles shouldn't be written off. They are a huge red flag for the economy and consumer staples sector as a whole.
Consumer Staples No Longer a Sure Bet
Stocks in the consumer staples sector are seen as being a defensive option if the markets hit turbulence, but high valuations are making the outlook less certain.
Health Insurers Hit by Medicare Rates
The health insurance sector took a beating after one of the biggest names in the business warned that premium Medicare payment rates will decline next year.
5 Valentine’s Day Stocks to Love or Leave
These five stocks cater to the romantics in the crowd, but don't think the ramped-up business around Valentine's Day will make all of them sizzle.
6 Health Care Provider Stocks to Buy Now
The grades of six Health Care Provider stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
10 Stocks for a Made-in-America Portfolio
The U.S. is starting to look like the least-ugly option in a globe full of uncertainty. If you agree, here are a few concentrated ways to play America.
Winners and Losers in Obama’s Second Term
Some companies are thrilled to see Obama return, others not so much. Here are the healthcare, finance, defense and gun stocks that will react and why.
Flu’s Pain Is All Gain for These Companies
As this year's flu season intensifies, so do the profits for some businesses such as vaccine makers, pharmacies and even certain food and beverage makers.
2 Stocks Looking to Scare Up a Short Squeeze
The shorts have been piling into Stanley Black & Decker and Aetna, but they could be sent fleeing later this month should the earnings needle point north.
Flu Season: Where Investors Can Find Relief
This year's flu looks particularly troublesome, but that's good new for the many companies that benefit from flu sufferers' ills. Here's a look at some of them.
